4.5 Article

Pneumonia infection in mice reveals the involvement of the feoA gene in the pathogenesis of Acinetobacter baumannii

Journal

VIRULENCE
Volume 9, Issue 1, Pages 496-509

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/21505594.2017.1420451

Keywords

Acinetobacter baumannii; iron uptake; virulence; animal infection models

Funding

  1. Conselleria de Cultura, Educacion y Ordenacion Universitaria Xunta de Galicia-Spain
  2. Miguel Servet program-ISCIII-Spain
  3. Sara Borrell Program-ISCIIII-Spain
  4. REIPI-Spain
  5. SEIMC-Spain
  6. ISCIIII-Spain

Ask authors/readers for more resources

Acinetobacter baumannii has emerged in the last decade as an important nosocomial pathogen. To identify genes involved in the course of a pneumonia infection, gene expression profiles were obtained from A. baumannii ATCC 17978 grown in mouse infected lungs and in culture medium. Gene expression analysis allowed us to determine a gene, the A1S_0242 gene (feoA), over-expressed during the pneumonia infection. In the present work, we evaluate the role of this gene, involved in iron uptake. The inactivation of the A1S_0242 gene resulted in an increase susceptibility to oxidative stress and a decrease in biofilm formation, in adherence to A549 cells and in fitness. In addition, infection of G. mellonella and pneumonia in mice showed that the virulence of the Delta 0242 mutant was significantly attenuated. Data presented in this work indicated that the A1S_0242 gene from A. baumannii ATCC 17978 strain plays a role in fitness, adhesion, biofilm formation, growth, and, definitively, in virulence. Taken together, these observations show the implication of the feoA gene plays in the pathogenesis of A. baumannii and highlight its value as a potential therapeutic target.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Microbiology

Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections

Alba Ruedas-Lopez, Isaac Alonso-Garcia, Cristina Lasarte-Monterrubio, Paula Guijarro-Sanchez, Eva Gato, Juan Carlos Vazquez-Ucha, Juan Andres Vallejo, Pablo Arturo Fraile-Ribot, Begona Fernandez-Perez, David Velasco, Jose Maria Gutierrez-Urbon, Marina Oviano, Alejandro Beceiro, Concepcion Gonzalez-Bello, Antonio Oliver, Jorge Arca-Suarez, German Bou

Summary: This study aimed to analyze the resistance mechanisms of ceftolozane-tazobactam and ceftazidime-avibactam in multidrug-resistant or extensively drug-resistant P. aeruginosa isolates. The findings revealed that most of the resistant isolates were recovered after treatment with ceftolozane-tazobactam or ceftazidime-avibactam. Chromosomal mutations and specific gene substitutions were identified as the main resistance mechanisms. The study emphasized the potential selection of MDR/XDR P. aeruginosa strains producing certain variants or metallo-beta-lactamases by cephalosporin/beta-lactamase inhibitors, and encouraged judicious use of these agents.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Microbiology

In Vitro Activity of Cefepime-Taniborbactam against Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa Isolates Recovered in Spain

Marta Hernandez-Garcia, Maria Garcia-Castillo, Patricia Ruiz-Garbajosa, German Bou, Maria Siller-Ruiz, Cristina Pitart, Irene Gracia-Ahufinger, Xavier Mulet, Alvaro Pascual, Nuria Tormo, Rafael Canton

Summary: This study evaluated the activity of cefepime-taniborbactam against carbapenemase-producing bacteria and found it to be effective against both Enterobacterales and Pseudomonas species.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Microbiology

Assessment of Activity and Resistance Mechanisms to Cefepime in Combination with the Novel β-Lactamase Inhibitors Zidebactam, Taniborbactam, and Enmetazobactam against a Multicenter Collection of Carbapenemase-Producing Enterobacterales

Juan Carlos Vazquez-Ucha, Cristina Lasarte-Monterrubio, Paula Guijarro-Sanchez, Marina Oviano, Laura Alvarez-Fraga, Isaac Alonso-Garcia, Jorge Arca-Suarez, German Bou, Alejandro Beceiro

Summary: The global distribution of carbapenemases is a concern due to their resistance to traditional beta-lactamase inhibitors. The development of new inhibitors shows promise in treating multidrug-resistant bacteria. The combination of cefepime with novel beta-lactamase inhibitors, zidebactam, taniborbactam, and enmetazobactam, demonstrated high activity against carbapenemase-producing Enterobacterales, particularly cefepime/zidebactam and cefepime/taniborbactam.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Review Biochemistry & Molecular Biology

Microbiome in Immune-Mediated Uveitis

Carmen Antia Rodriguez-Fernandez, Manuel Busto Iglesias, Begona de Domingo, Kelly Conde-Perez, Juan A. Vallejo, Lorena Rodriguez-Martinez, Miguel Gonzalez-Barcia, Victor Llorenc, Cristina Mondelo-Garcia, Margarita Poza, Anxo Fernandez-Ferreiro

Summary: This review summarizes the potential role of intestinal dysbiosis in the pathogenesis of non-infectious uveitis (NIU) and discusses the potential of modulating the gut microbiota as a therapeutic target. Furthermore, it highlights the evidence suggesting that treatment with anti-TNF can restore the composition of the gut microbiota and predict the response of patients to treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Immunology

A New Live Auxotrophic Vaccine Induces Cross-Protection against Klebsiella pneumoniae Infections in Mice

Miriam Moscoso, Juan A. Vallejo, Maria P. Cabral, Patricia Garcia, Victor Fuentes-Valverde, Eva Gato, Jorge Arca-Suarez, Pablo Aja-Macaya, German Bou

Summary: This article describes a prototype vaccine for preventing Klebsiella pneumoniae infections, which is constructed using a glutamate racemase-deficient mutant. The results show that this mutant can induce a strong immune response and provide cross-protection against systemic infections caused by highly virulent and multidrug-resistant strains of K. pneumoniae, with a high level of safety.

VACCINES (2022)

Article Biotechnology & Applied Microbiology

A new and efficient enrichment method for metagenomic sequencing of Monkeypox virus

Pablo Aja-Macaya, Soraya Rumbo-Feal, Margarita Poza, Angelina Canizares, Juan A. A. Vallejo, German Bou

Summary: A new method for extraction and enrichment of genomic MPXV DNA was developed, which significantly improved the sequencing efficiency and trustworthiness of the consensus sequences. Enriched samples contained a higher percentage of MPXV reads compared to non-enriched samples, leading to more accurate and cost-effective diagnosis of contagious diseases.

BMC GENOMICS (2023)

Article Infectious Diseases

Activity of aztreonam in combination with novel ,B-lactamase inhibitors against metallo- ,B-lactamase-producing Enterobacterales from Spain

Juan Carlos Vazquez-Ucha, Isaac Alonso-Garcia, Paula Guijarro-Sanchez, Cristina Lasarte-Monterrubio, Laura Alvarez-Fraga, Arnau Cendon-Esteve, Michelle Outeda, Romina Maceiras, Andrea Pena-Escolano, Marta Martinez-Guitian, Jorge Arca-Suarez, German Bou, Alejandro Beceiro

Summary: Metallo- ,B-lactamase (MBL)-producing Enterobacterales, which are resistant to almost all ,B-lactam antibiotics, pose a significant threat due to their wide dissemination and difficulty in treatment. This study evaluated the activity of aztreonam in combination with novel ,B-lactamase inhibitors (BLIs) against clinical isolates co-producing MBLs and SBLs. The results showed that aztreonam/zidebactam, aztreonam/avibactam, and aztreonam/taniborbactam were the most effective combinations, offering promising therapeutic strategies for difficult-to-treat infections.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Article Microbiology

Antimicrobial Activity of Cefiderocol against the Carbapenemase-Producing Enterobacter cloacae Complex and Characterization of Reduced Susceptibility Associated with Metallo-β-Lactamase VIM-1

Cristina Lasarte-Monterrubio, Paula Guijarro-Sanchez, Juan Carlos Vazquez-Ucha, Isaac Alonso-Garcia, Laura Alvarez-Fraga, Michelle Outeda, Marta Martinez-Guitian, Andrea Pena-Escolano, Romina Maceiras, Emilio Lence, Concepcion Gonzalez-Bello, Jorge Arca-Suarez, German Bou, Alejandro Beceiro

Summary: Resistance to cefiderocol has emerged among carbapenemase-producing Enterobacterales, particularly in the Enterobacter cloacae complex. This resistance is mainly due to the production of VIM-1 carbapenemase and may also involve the co-production of SHV-12 and inactivation of the FcuA-like siderophore receptor.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2023)

Article Infectious Diseases

Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR Pseudomonas aeruginosa infections

Isaac Alonso-Garcia, Juan Carlos Vazquez-Ucha, Cristina Lasarte-Monterrubio, Elena Gonzalez-Mayo, Paula Lada-Salvador, Ramon Vela-Fernandez, Pablo Aja-Macaya, Paula Guijarro-Sanchez, Soraya Rumbo-Feal, Maria Muino-Andrade, Ana Fernandez-Gonzalez, Marta Martinez-Guitian, Alejandro Beceiro, Manuel Rodriguez-Iglesias, Antonio Oliver, Jorge Arca-Suarez, Fatima Galan-Sanchez, German Bou

Summary: This study described and characterized the emergence of resistance to ceftolozane/tazobactam, ceftazidime/avibactam, and imipenem/relebactam in a patient with MDR Pseudomonas aeruginosa central nervous system infection. Mutational changes in the bacteria's genes were investigated through whole genome sequencing, and it was found that mutations in the P PDC beta-lactamase and MexAB-OprM regulator MexR played a role in the development of resistance. Cloning experiments and complementation assays confirmed the impact of the mutations on resistance. The study highlights the ability of P. aeruginosa to develop resistance and compromise the activity of new beta-lactam/beta-lactamase inhibitor combinations.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2023)

Article Infectious Diseases

Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales

Isaac Alonso-Garcia, Juan Carlos Vazquez-Ucha, Marta Martinez-Guitian, Cristina Lasarte-Monterrubio, Salud Rodriguez-Pallares, Pablo Camacho-Zamora, Soraya Rumbo-Feal, Pablo Aja-Macaya, Lucia Gonzalez-Pinto, Michelle Outeda-Garcia, Romina Maceiras, Paula Guijarro-Sanchez, Maria Jose Muino-Andrade, Ana Fernandez-Gonzalez, Marina Oviano, Concepcion Gonzalez-Bello, Jorge Arca-Suarez, Alejandro Beceiro, German Bou

Summary: The impact of the β-lactamase OXA-10 on carbapenem resistance in Enterobacterales was investigated through various experiments. The results demonstrated that OXA-10 contributes to increased carbapenem minimum inhibitory concentrations when combined with porin deficiency. However, OXA-10 was not detected using standard biochemical tests.

ANTIBIOTICS-BASEL (2023)

Article Oncology

Parvimonas micra can translocate from the subgingival sulcus of the human oral cavity to colorectal adenocarcinoma

Kelly Conde-Perez, Elena Buetas, Pablo Aja-Macaya, Elsa Martin-De Arribas, Iago Iglesias-Corras, Noelia Trigo-Tasende, Mohammed Nasser-Ali, Lara S. Estevez, Soraya Rumbo-Feal, Begona Otero-Alen, Jose F. Noguera, Angel Concha, Simon Pardinas-Lopez, Miguel Carda-Dieguez, Igor Gomez-Randulfe, Nieves Martinez-Lago, Susana Ladra, Luis A. Aparicio, German Bou, Alex Mira, Juan A. Vallejo, Margarita Poza

Summary: This study analyzed oral and intestinal samples from CRC patients and healthy controls using 16S metabarcoding and/or RNA sequencing. The analysis revealed that Parvimonas was significantly over-represented in feces from CRC patients compared to healthy controls. Isolates of Parvimonas micra were obtained from the oral cavity and adenocarcinoma of CRC patients, suggesting its translocation from the mouth to the gut. The study suggests that P. micra could be used as a CRC biomarker detected in non-invasive samples such as feces.

MOLECULAR ONCOLOGY (2023)

Article Environmental Sciences

Wastewater early warning system for SARS-CoV-2 outbreaks and variants in a Coruna, Spain

Noelia Trigo-Tasende, Juan A. Vallejo, Soraya Rumbo-Feal, Kelly Conde-Perez, Manuel Vaamonde, Angel Lopez-Oriona, Ines Barbeito, Mohammed Nasser-Ali, Ruben Reif, Bruno K. Rodino-Janeiro, Elisa Fernandez-Alvarez, Iago Iglesias-Corras, Borja Freire, Javier Tarrio-Saavedra, Laura Tomas, Pilar Gallego-Garcia, David Posada, German Bou, Ignacio Lopez-de-Ullibarri, Ricardo Cao, Susana Ladra, Margarita Poza

Summary: The wastewater-based epidemiology program COVIDBENS in A Coruna, Spain, monitored viral load and detected SARS-CoV-2 mutations in wastewater using RT-qPCR and Illumina sequencing. It successfully predicted community outbreaks and identified new variants, providing early warning to local authorities and health managers.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2023)

No Data Available